Osiris Therapeutics Inc. stock has received a delisting notice from the Nasdaq Stock Exchange and will be suspended from trading when the market opens Tuesday. The news sent Osiris shares down more than 10 percent Monday morning, trading at $4.66 per share. Osiris did not file its delinquent financial reports with the U.S. Securities Exchange Commission, the company reported Friday. Nasdaq warned the Columbia biotech in December that if it did not become current with its financial filings by March…
from http://www.bizjournals.com/baltimore/news/2017/03/13/osiris-shares-tumble-on-delisting-notice.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/158354395282
No comments:
Post a Comment